Ensysce Biosciences, Inc. Common Stock (ENSC) is a publicly traded Healthcare sector company. As of May 21, 2026, ENSC trades at $0.30 with a market cap of $2.94M and a P/E ratio of -0.08. ENSC moved +3.27% today. Year to date, ENSC is -70.19%; over the trailing twelve months it is -87.19%. Its 52-week range spans $0.23 to $14.67. Rallies surfaces ENSC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
ENSC financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ENSC recently traded at $0.30. Market cap is $2.94M. P/E ratio is -0.08. Revenue is $5.07M.
| Metric | Value |
|---|---|
| Price | $0.30 |
| Market Cap | $2.94M |
| P/E Ratio | -0.08 |
| EPS | $-3.98 |
| Dividend Yield | 0.00% |
| 52-Week High | $14.67 |
| 52-Week Low | $0.23 |
| Volume | 33.24K |
| Avg Volume | 0 |
| Revenue (TTM) | $5.07M |
| Net Income | $-10.18M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $5.07M | $-10.18M | $-3.98 |
| 2024 | $5.21M | $-7.99M | $-11.45 |
| 2023 | $2.23M | $-10.63M | $-4.69 |
| 2022 | $2.52M | $-24.21M | $-11.62 |
ENSC analyst coverage data. Average price target: $0.00.